Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera

被引：0
作者：
A Tefferi
J J Strand
T L Lasho
R A Knudson
C M Finke
N Gangat
A Pardanani
C A Hanson
R P Ketterling
机构：
[1] Mayo Clinic,Division of Hematology
[2] Laboratorie of Cytogenetics,undefined
[3] Mayo Clinic,undefined
[4] Laboratorie of Hematopathology,undefined
[5] Mayo Clinic,undefined
来源：
Leukemia | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2074 / 2075
页数：1
相关论文
共 33 条
  • [1] Scott LM(2007)JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis N Engl J Med 356 459-468
  • [2] Tong W(2006)The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera Cancer 106 631-635
  • [3] Levine RL(2006)A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis Leukemia 20 1055-1060
  • [4] Scott MA(2006)X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis Blood 107 4139-4141
  • [5] Beer PA(2007)Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years Blood 109 1241-1243
  • [6] Stratton MR(2007)Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients Leukemia 21 270-276
  • [7] Tefferi A(undefined)undefined undefined undefined undefined-undefined
  • [8] Lasho TL(undefined)undefined undefined undefined undefined-undefined
  • [9] Schwager SM(undefined)undefined undefined undefined undefined-undefined
  • [10] Strand JS(undefined)undefined undefined undefined undefined-undefined
1234